OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001557376

Zeo ScientifiX, Inc. (ZEOX)

Zeo ScientifiX, Inc. (CIK 0001557376, ticker ZEOX, EIN 47-4180540) reported revenue of $5.2 million ($5,199,000) for FY2024 (2024-11-01 to 2025-10-31) and net income of -$5.52 million (-$5,521,000) for FY2024 (2024-11-01 to 2025-10-31), as filed in its 10-K filed 2026-01-29 (accession 0001829126-26-000763).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends June 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001557376
TickersZEOX (OTC)
EIN47-4180540
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationNV
Fiscal year endJune 30
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_4bk0s92z8a2tjbetfpnzgqke51
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$5,199,000FY20242024-11-01 to 2025-10-3110-K2026-01-290001829126-26-000763Revenues
Net income-$5,521,000FY20242024-11-01 to 2025-10-3110-K2026-01-290001829126-26-000763NetIncomeLoss
Total assets$1,527,000FY2024as of 2025-10-3110-K2026-01-290001829126-26-000763Assets
Total liabilities$2,950,000FY2024as of 2025-10-3110-K2026-01-290001829126-26-000763Liabilities
Stockholders' equity-$1,423,000FY2024as of 2025-10-3110-K2026-01-290001829126-26-000763StockholdersEquity
Operating cash flow-$718,000FY20242024-11-01 to 2025-10-3110-K2026-01-290001829126-26-000763NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.86 per shareFY20242024-11-01 to 2025-10-3110-K2026-01-290001829126-26-000763EarningsPerShareDiluted
Shares outstanding7,614,941 sharesFY2024as of 2026-01-2810-K2026-01-290001829126-26-000763EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2015-2024, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20242024-11-01 to 2025-10-31$5,199,00010-K2026-01-290001829126-26-000763
RevenueFY20242023-11-01 to 2024-10-31$4,620,00010-K2026-01-290001829126-26-000763
RevenueFY20232022-11-01 to 2023-10-31$4,558,00010-K2025-01-290001829126-25-000536
RevenueFY20222021-11-01 to 2022-10-31$6,491,00810-K2024-01-290001829126-24-000541
RevenueFY20212020-11-01 to 2021-10-31$5,597,48710-K2023-02-140001829126-23-001524
RevenueFY20202019-11-01 to 2020-10-31$3,055,77610-K2022-02-140001829126-22-003605
RevenueFY20192018-11-01 to 2019-10-31$1,702,27110-K2021-02-080001829126-21-000414
RevenueFY20182017-11-01 to 2018-10-31$964,53010-K2020-10-160001683168-20-003466
RevenueFY20172016-11-01 to 2017-10-31$569,84510-K2020-03-060001683168-20-000712
RevenueFY20162015-11-01 to 2016-10-31$184,88110-K2018-11-010001683168-18-003206
RevenueFY20152014-11-01 to 2015-10-31$147,62910-K2017-07-070001493152-17-007610
Net incomeFY20242024-11-01 to 2025-10-31-$5,521,00010-K2026-01-290001829126-26-000763
Net incomeFY20242023-11-01 to 2024-10-31-$4,705,00010-K2026-01-290001829126-26-000763
Net incomeFY20232022-11-01 to 2023-10-31-$6,987,00010-K2025-01-290001829126-25-000536
Net incomeFY20222021-11-01 to 2022-10-31-$8,896,55710-K2024-01-290001829126-24-000541
Net incomeFY20212020-11-01 to 2021-10-31-$12,756,56010-K2023-02-140001829126-23-001524
Net incomeFY20202019-11-01 to 2020-10-31-$12,582,96710-K2022-02-140001829126-22-003605
Net incomeFY20192018-11-01 to 2019-10-31-$1,737,32110-K2021-02-080001829126-21-000414
Net incomeFY20182017-11-01 to 2018-10-31-$3,462,15810-K2020-10-160001683168-20-003466
Net incomeFY20172016-11-01 to 2017-10-31-$8,972,13210-K2020-03-060001683168-20-000712
Net incomeFY20162015-11-01 to 2016-10-31-$1,253,20110-K2018-11-010001683168-18-003206
Net incomeFY20152014-11-01 to 2015-10-31-$738,35410-K2017-07-070001493152-17-007610
  • Revenue for FY2023 was restated: first reported as $4,558,278 (accession 0001829126-24-000541, filed 2024-01-29).
  • Net income for FY2023 was restated: first reported as -$6,986,708 (accession 0001829126-24-000541, filed 2024-01-29).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-06-152026-04-300001829126-26-006486zeoscientifix_10q.htm
10-Q2026-03-172026-01-310001829126-26-002396zeoscientifix_10q.htm
10-K2026-01-292025-10-310001829126-26-000763zeoscientifix_10k.htm
10-Q2025-09-152025-07-310001829126-25-007398zeoscientifix_10q.htm
10-Q2025-06-162025-04-300001829126-25-004512zeoscientifix_10q.htm
10-Q2025-03-172025-01-310001829126-25-001828zeoscientifix_10q.htm
10-K2025-01-292024-10-310001829126-25-000536zeoscientifix_10k.htm
10-Q2024-09-162024-07-310001829126-24-006296zeoscientifix_10q.htm
10-Q2024-06-142024-04-300001829126-24-004217zeoscientifix_10q.htm
10-Q2024-03-182024-01-310001829126-24-001677zeoscientifixinc_10q.htm
10-K2024-01-292023-10-310001829126-24-000541organicellregen_10k.htm
10-Q2023-09-142023-07-310001829126-23-006098organicellregen_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001557376published by the sourcedata.sec.gov/submissions/CIK0001557376.json2026-10-21
Employer Identification Number (EIN) · US-EIN47-4180540published by the sourcedata.sec.gov/submissions/CIK0001557376.json2026-10-21

Former names

NameFromTo
Organicell Regenerative Medicine, Inc.2018-06-252024-01-29
Biotech Products Services & Research, Inc.2015-09-172018-06-15
BESPOKE TRICYCLES INC2012-09-042015-09-14

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001557376.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001557376.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001557376" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001557376/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001557376/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1557376"}

On SEC EDGAR

About this data